Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-01-18 06:15 am Sale | 2022-01-14 | 13G | Crescent Biopharma, Inc. CBIO | Assenagon Asset Management S.A. | 0 0.000% | -4,759 (Position Closed) | Filing History |
| 2022-01-18 06:12 am Purchase | 2022-01-13 | 13G | Crescent Biopharma, Inc. CBIO | Assenagon Asset Management S.A. | 4,759 5.980% | 1,933 (+68.39%) | Filing History |
| 2021-11-24 09:13 am Sale | 2021-11-24 | 13G | Minerva Neurosciences, Inc. NERV | Assenagon Asset Management S.A. | 173,186 3.240% | -586,978 (-77.22%) | Filing History |
| 2021-11-24 09:11 am Purchase | 2021-11-23 | 13G | Minerva Neurosciences, Inc. NERV | Assenagon Asset Management S.A. | 760,164 14.230% | 760,164 (New Position) | Filing History |